Sionna Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SION and other ETFs, options, and stocks.About SION
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis.
CEOMichael Cloonan
CEOMichael Cloonan
Employees41
Employees41
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2019
Founded2019
Employees41
Employees41
SION Key Statistics
Market cap1.75B
Market cap1.75B
Price-Earnings ratio-24.47
Price-Earnings ratio-24.47
Dividend yield—
Dividend yield—
Average volume310.60K
Average volume310.60K
High today$40.97
High today$40.97
Low today$38.52
Low today$38.52
Open price$38.90
Open price$38.90
Volume264.48K
Volume264.48K
52 Week high$45.00
52 Week high$45.00
52 Week low$7.26
52 Week low$7.26
Stock Snapshot
Sionna Therapeutics(SION) stock is priced at $39.13, giving the company a market capitalization of 1.75B. It carries a P/E multiple of -24.47.
As of 2026-01-17, Sionna Therapeutics(SION) stock has fluctuated between $38.52 and $40.97. The current price stands at $39.13, placing the stock +1.6% above today's low and -4.5% off the high.
The Sionna Therapeutics(SION)'s current trading volume is 264.48K, compared to an average daily volume of 310.6K.
In the last year, Sionna Therapeutics(SION) shares hit a 52-week high of $45.00 and a 52-week low of $7.26.
In the last year, Sionna Therapeutics(SION) shares hit a 52-week high of $45.00 and a 52-week low of $7.26.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
0%
Sell
11.1%
People also own
Based on the portfolios of people who own SION. This list is generated using Robinhood data, and it’s not a recommendation.